TGFB1 and Hepatic fibrosis: Loss of STAT5 in hepatocytes enhanced GH-induced STAT3 activity and increased TGF-β levels after CCl4 intervention, and STAT5 deficiency also increased the sensitivity of Kupffer or hepatic stellate cells to TGF-β and pro-hepatic fibrosis [82].